These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 6085004)

  • 1. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
    Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
    Whittle BJ; Moncada S; Whiting F; Vane JR
    Prostaglandins; 1980 Apr; 19(4):605-27. PubMed ID: 6992234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
    Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
    Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).
    Aiken JW; Shebuski RJ
    Prostaglandins; 1980 Apr; 19(4):629-43. PubMed ID: 6992235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance and pharmacology of ciprostene, a stable epoprostenol (prostacyclin) analogue in humans.
    Linet OI; Nishizawa EE; Schaub RG; VanderLugt JT; Greenwald CA
    J Clin Pharmacol; 1986 Feb; 26(2):131-40. PubMed ID: 3005377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
    Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prostacyclin analogue (carbacyclin) on the interaction of platelets with different collagen substrates. Inhibition of cAMP increase by collagens type I, III, and IV.
    Mazurov AV; Misselwitz F; Hoffman U; Leytin VL; Repin VS
    Prostaglandins; 1988 Jan; 35(1):51-65. PubMed ID: 2836888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
    Hamid S; Whittle BJ
    Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB; Miller OV; Spillers C; Gorman RR
    Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the inhibitory effects of prostacyclin and carbacyclin on platelet adhesion to collagen.
    Karniguian A; Simmons P; Legrand YJ; Moncada S; Caen JP
    Prostaglandins; 1982 Dec; 24(6):827-36. PubMed ID: 6300971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteers.
    Belch JJ; Greer I; McLaren M; Saniabadi AR; Miller S; Sturrock RD; Forbes CD
    Prostaglandins; 1984 Jul; 28(1):67-77. PubMed ID: 6207561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N
    Arzneimittelforschung; 1986 Aug; 36(8):1180-3. PubMed ID: 3096342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of prostaglandins and an aortic proteoglycan on platelet aggregation and plasma clotting.
    Ts'ao C; Eisenstein R
    Prostaglandins Med; 1979 Sep; 3(3):159-66. PubMed ID: 399532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous infusion of prostacyclin (PGI2) in man.
    O'Grady J; Warrington S; Moti MJ; Bunting S; Flower R; Fowle AS; Higgs EA; Moncada S
    Prostaglandins; 1980 Feb; 19(2):319-32. PubMed ID: 6992228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat.
    Stürzebecher S; Haberey M; Müller B; Schillinger E; Schröder G; Skuballa W; Stock G; Vorbrüggen H; Witt W
    Prostaglandins; 1986 Jan; 31(1):95-109. PubMed ID: 3513260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased platelet activity after termination of prostacyclin infusion into man.
    Dembinska-Kiec A; Zmuda A; Grodzinska L; Bieron K; Basista M; Kedzior A; Kostka-Trabka E; Telesz E; Zelazny T
    Prostaglandins; 1981 May; 21(5):827-32. PubMed ID: 6803307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.
    Hassan S; Pickles H; Fish A; Burke C; Warrington S; O'Grady J
    Br J Clin Pharmacol; 1982 Sep; 14(3):369-77. PubMed ID: 6127095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
    Buttrick PM; Forscher CA; Sussman II; Mueller HS
    Am Heart J; 1985 Jun; 109(6):1258-63. PubMed ID: 2988323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.